(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 23.16% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Hyperfine's revenue in 2025 is $12,890,000.On average, 2 Wall Street analysts forecast HYPR's revenue for 2025 to be $1,213,404,279, with the lowest HYPR revenue forecast at $1,176,823,136, and the highest HYPR revenue forecast at $1,249,985,421. On average, 1 Wall Street analysts forecast HYPR's revenue for 2026 to be $1,642,259,800, with the lowest HYPR revenue forecast at $1,642,259,800, and the highest HYPR revenue forecast at $1,642,259,800.
In 2027, HYPR is forecast to generate $1,739,550,072 in revenue, with the lowest revenue forecast at $1,739,550,072 and the highest revenue forecast at $1,739,550,072.